Stability of Syk protein and mRNA in human peripheral blood basophils.

about

Stability of Syk protein and mRNA in human peripheral blood basophils.

Item

http://www.wikidata.org/entity/Q42360949

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Stability of Syk protein and mRNA in human peripheral blood basophils.

@en

Stability of Syk protein and mRNA in human peripheral blood basophils.

@nl

type

Item

label

Stability of Syk protein and mRNA in human peripheral blood basophils.

@en

Stability of Syk protein and mRNA in human peripheral blood basophils.

@nl

prefLabel

Stability of Syk protein and mRNA in human peripheral blood basophils.

@en

Stability of Syk protein and mRNA in human peripheral blood basophils.

@nl

P1476

Stability of Syk protein and mRNA in human peripheral blood basophils.

@en

P2093

Donald MacGlashan

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex

Global quantification of mammalian gene expression control

Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.

Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Human cord blood derived immature basophils show dual characteristics, expressing both basophil and eosinophil associated proteins.

Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Expression profiling of human basophils: modulation by cytokines and secretagogues

Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors

P304

535-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1189/JLB.2A0815-356R

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26980801

http://www.w3.org/2001/XMLSchema#string

P932

4982608

http://www.w3.org/2001/XMLSchema#string